Literature DB >> 8143410

Colour Doppler studies of axillary node metastases in breast carcinoma.

J S Walsh1, J M Dixon, U Chetty, D Paterson.   

Abstract

Colour Doppler scans were carried out on 80 patients with breast carcinoma. Both the tumour and the lower axilla were scanned in all 80 patients. Seventy-five patients subsequently underwent axillary lymph node dissection and histological examination. The sensitivity of colour Doppler scanning for axillary node involvement was 70%, with a specificity of 98% and a positive predictive value of 96%.

Entities:  

Mesh:

Year:  1994        PMID: 8143410     DOI: 10.1016/s0009-9260(05)81774-x

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

1.  Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography.

Authors:  W W Lam; W T Yang; Y L Chan; I E Stewart; C Metreweli; W King
Journal:  Eur J Nucl Med       Date:  1996-05

2.  Selective application of routine preoperative axillary ultrasonography reduces costs for invasive breast cancers.

Authors:  Kiran K Turaga; Alec Chau; Jennifer M Eatrides; John V Kiluk; Nazanin Khakpour; Christine Laronga; M Catherine Lee
Journal:  Oncologist       Date:  2011-05-14

3.  Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Authors:  I C Smith; K N Ogston; P Whitford; F W Smith; P Sharp; M Norton; I D Miller; A K Ah-See; S D Heys; J A Jibril; O Eremin
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

4.  Ultrasound assessment of residual abnormalities following primary chemotherapy for breast cancer.

Authors:  M T Seymour; E C Moskovic; G Walsh; P Trott; I E Smith
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Imaging in evaluation of response to neoadjuvant breast cancer treatment.

Authors:  L Ollivier; C Balu-Maestro; J Leclère
Journal:  Cancer Imaging       Date:  2005-05-24       Impact factor: 3.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.